Respiratory syncytial virus: Time for surveillance across all ages, with a focus on adults

Author:

Bont Louis12,Krone Manuel34,Harrington Lauriane5,Nair Harish267,Nolan Terry89,Oshitani Hitoshi10,Salisbury David11

Affiliation:

1. Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands

2. ReSViNET Foundation, Julius Clinical, Zeist, the Netherlands

3. Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany

4. Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany

5. GSK, Wavre, Belgium

6. Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, Scotland, UK

7. MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

8. Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia

9. Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

10. Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan

11. Programme for Global Health, Royal Institute of International Affairs, Chatham House, London, England, UK

Publisher

International Society of Global Health

Reference10 articles.

1. Respiratory Syncytial Virus Infection: An Illness for All Ages.;Walsh;Clin Chest Med,2017

2. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis.;Savic;Influenza Other Respir Viruses,2023

3. Centers for Disease Control and Prevention. RSV in older adults and adults with chronic medical conditions. 2022. Available: https://www.cdc.gov/rsv/high-risk/older-adults.html. Accessed: 12 April 2023.

4. The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review.;Chuang;Infect Drug Resist,2023

5. Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017.;Mollers;Euro Surveill,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3